Kusajili – Clinical trials directory

Result of your search per sponsor: AbbVie Stemcentrx LLC

Woman and Man Max 99 years
AbbVie Stemcentrx LLC Update Il y a 4 ans

A Clinical Trial to observe the effects of the test drug Rovalpituzumab Tesirine in patients with a particular form of Lung Cancer where no lasting efficacy has been achieved on at least two previous therapies To investigate the efficacy of rovalpituzumab tesirine as third-line and later treatment for subjects with relapsed or refractory delta-like protein 3 (DLL3)-expressing small cell lung cancer (SCLC)

Country None
organs None
Specialty None

unknown

More information